Digest Network Come funziona
Network
/
Società
Se
Non verificato

Seaport Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

11 comunicati stampa

Guarda tutti i comunicati
28/10/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Web e Social Network
Eventi
Finanza
Seaport Therapeutics to Present at Stifel 2026 Healthcare Conference
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/10/2026
Eventi
Industria
Biotecnologia
Farmaceutica
Salute
Psichiatria
Attrezzature medico-sanitarie
Medicina - Varie
Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/10/2026
Industria
Psichiatria
Salute
Farmaceutica
Medicina - Varie
Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/09/2026
Psichiatria
Scienza
Medicina - Varie
Salute
Farmaceutica
Web e Social Network
Eventi
Seaport Therapeutics to Participate in September Investor Conferences
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/09/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
31/08/2026
Eventi
Web e Social Network
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
03/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Igiene alimentare
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/06/2026
Mercato azionario
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/06/2026
Industria
Farmaceutica
Salute
Medicina - Varie
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0
01/06/2026
Eventi
Web e Social Network
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
Fonte
Seaport Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0